Transcription factor-microRNA associations and their impact on colorectal cancer survival

Lila E Mullany1, Jennifer S Herrick1, Roger K Wolff1

  • 1Department of Internal Medicine, University of Utah, Salt Lake City, Utah.

Insights

Transcription Factors (TFs) and microRNAs (miRNAs) impact colorectal cancer survival. This study identified specific TF-miRNA interactions affecting patient prognosis, offering new insights into cancer development and survival.

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • MicroRNAs (miRNAs) and Transcription Factors (TFs) regulate gene expression, influencing cancer development and patient outcomes.
  • The complex interplay of miRNAs and TFs in carcinogenesis makes it challenging to identify key players affecting cancer survival.

Purpose of the Study:

  • To investigate the association between TF expression and survival in colon cancer patients.
  • To identify miRNAs linked to survival-associated TFs.
  • To determine if TF-specific miRNA expression patterns influence survival in colorectal cancer.

Main Methods:

  • Survival analysis using Cox Proportional hazard models was performed.
  • Associations between TF expression and miRNA expression in normal colonic mucosa were analyzed.
  • Principal Component Analysis (PCA) was used to derive factors from TF-specific miRNA expression patterns.

Main Results:

  • Thirty TFs were associated with improved survival in colon cancer.
  • 27 of these TFs showed significant associations with 65 unique miRNAs.
  • Five miRNA-derived factors, including one that reduced survival, impacted rectal cancer survival; one factor comprising four miRNAs reduced colon cancer survival.

Conclusions:

  • TF and related miRNA expression significantly influence survival in colorectal cancer patients.
  • Identifying specific TF-miRNA interactions can provide prognostic biomarkers.
  • This research highlights the critical role of gene regulatory networks in colorectal cancer progression.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
4.2K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
24.4K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
7.9K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K